| 
      
        |  |  |  
        |  |  
        |  | Dictionary |  |  
        | 
           
         
 | 3,5-Dibromo-2-[[[[(2,4-dichlorophenoxy)acetyl ]amino]thioxomethyl ]amino]-benzoic acid |  | Sodium 4-[[5-amino-1-(4-chlorophenyl)-3-methyl-1h-pyrazol-4-yl ]azo]-2,5-dichlorobenzenesulphonate |  | Gefitinib hydrochloride |  | Bepridil hydrochloride |  | Azd-9291 (mesylate) |  | Peramivir trihydrate |  | Azd-8055-d(-)-tartaric acid |  | Ly2886721 hcl |  | 8-Boc-1,8-diazaspiro[4.5]decane oxalate |  | Wst-5 |  | Trilithium [[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl] [[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrof |  | Nalpha-tert-butoxycarbonyl-l-norvaline |  | (+/-)-Trans-4-(2-pyridinyl)pyrrolidine-3-carboxylic acid dihydrochloride |  | Lithium 4-[(5-amino-3-methyl-1-phenyl-1h-pyrazol-4-yl)azo]-2,5-dichlorobenzenesulphonate |  | Trimethyl-3-[[(tridecafluorohexyl)sulphonyl ]amino]propylammonium chloride |  | (2-Hydroxytrimethylene)bis[(3-chloro-2-hydroxypropyl)dimethylammonium] dichloride |  | Ethanone, 2-[(4-chloro[1,1-biphenyl]-4-yl)oxy]-1-(2,4-dichlorophenyl)-2-(1h-imidazol-1-yl)-, monohydrochloride (9ci) |  | Ethanone, 2-(4-chloro-2-methylphenoxy)-1-(2,4-dichlorophenyl)-2-(1h-imidazol-1-yl)-, monohydrochloride (9ci) |  | Ethanone, 1-(2,4-dichlorophenyl)-2-(1h-imidazol-1-yl)-2-(4-methylphenoxy)-, monohydrochloride (9ci) |  | Reactive red 180 |  | Thymidine 5 |  | (2,3-Dimethoxyphenyl)-4-piperidinylmethanone trifluoroacetate |  | Benzenesulfonic acid, 2,2-(1,2-ethenediyl)bis[ 5-[[1,4-dihydro-4-oxo-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt |  | Benzenesulfonic acid, 4,4-[1,3-phenylenebis[azo( 4,6-diamino-3,1-phenylene)azo]]bis-, disodium salt |  | [2,2-Bibenzo[b]thiophene]-3,3-diol, 6,6-dichloro-4,4-dimethyl-, bis(hydrogen sulfate), disodium salt |  | Glutathione-glycine-13c2,15n1 |  | Benzenesulfonic acid, 2,2-[(2-methyl-3,6-dioxo-1,4-cyclohexadiene-1,4-diyl)bis[imino(2-methyl-4 ,1-phenylene)imino]]bis[5-nitro-, disodium salt |  | 2-Naphthalenecarboxylic acid, 4-[(4-chloro-5-methyl-2-sulfophenyl) azo]-3-hydroxy-, disodium salt |  | Benzenesulfonic acid, 5-chloro-2-[4,5-dihydro-3-methyl-4-[[4-[[(4-methylphenyl)sulfonyl]oxy]phenyl ]azo]-5-oxo-1h-pyrazol-1-yl]-, sodium salt |  | 2,7-Anthracenedisulfonic acid, 4,5-diamino-9,10-dihydro-1,8-dihydroxy-9,10-dioxo-, disodium salt |  | Benzenesulfonic acid, 2,2-(1,2-ethenediyl)bis[ 5-[[4-[(2-hydroxyethyl)amino]-6-(phenylamino)-1,3 ,5-triazin-2-yl]amino]-, disodium salt |  | Benzenesulfonic acid, 2,2-(1,2-ethenediyl)bis[ 5-[[4-[(2-hydroxypropyl)amino]-6-methoxy-1,3,5-triazin-2-yl]amino]-, disodium salt |  | 2,3-Dichloro-4-methyl-6-nitrobenzotrifluoride |  | H-nle-obzl·tosoh |  | Fmoc-d-his(boc)-oh·cha |  | Toceranib phosphate |  | Ru(bpy)2(mcbpy-o-su-ester)(pf6)2 |  | Coenzyme a s-(hydrogen3-hydroxy-3-methyl pentanedioate) disodium salt |  | Lead(ii) bromate monohydrate. |  | Atpgammas |  | Rucl2[(s)-(dm-binap)][(s)-daipen] |  | 2S-n-cbz-homoserine  cyclohexanamine |  | 3,5-Dimethylmorpholine-4-carboxamidinehemisulfatesalt |  | Tris(n n-bis(trimethylsilyl)amide)scan& |  | Pentalithium [[[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-oxido-phosphoryl]oxy-oxido-phosphoryl]oxy-oxido-phosphoryl]oxy-oxido-phosphoryl] [(2r,3s,4r,5r)-5-(6-am |  | Direct black 166 |  | Hydrogen bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1h-pyrazol-4-yl)azo]-4-hydroxybenzene-1-sulphonamidato(2-)]chromate(1-) |  | Ethyl-2,3-dihydro-1h-isoindole-5-carboxylate trifluoroacetate |  | Methyl 2,3-dihydro-1h-isoindole-5-carboxylate trifluoroacetate |  | (4-(Oxazol-5-yl)phenyl)methanamine trifluoroacetate |  |  | 
      
        |  | Dictionary>135748-34-4 |  |  |  
        | 
 
            
              | Chemical Name: | 2-Chloro-4,5-difluorobenzonitrile |  
              | Synonyms: |  |  
              | CAS#: | 135748-34-4 |  
              | Molecular formula: | C7H2ClF2N |  
              | Molecular weight: | 173.55 |  
              | Molecular Structure: |  |  |  |